Plain-English translation of NCT07781358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination of two medications— and a PD-1 inhibitor—to treat nasopharyngeal cancer that has returned in the same area after previous treatment. The study will give you three cycles of these medications together, then assess whether surgery might help. After surgery or if surgery isn't an option, the medical team will decide on the best next steps for you.
Nasopharyngeal cancer that comes back after initial treatment is very difficult to manage, and doctors need better options to help patients. This trial is testing whether this medication combination can shrink the cancer enough to make surgery possible, or help control the disease in other ways.
You likely qualify if…
You likely don't qualify if…
You will receive three cycles of the two medications, likely given by infusion at a hospital or clinic. During this time, you'll have imaging scans (CT or MRI) and check-ups to see how well the treatment is working. If the cancer shrinks enough and you're healthy enough, you may have surgery to remove any remaining disease. After that, your medical team will decide whether you need more treatment or maintenance therapy to help keep the cancer from coming back.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
China